News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
VolitionRX Announces Proposed Public Offering Of Common Stock 9/30/2016
Amgen (AMGN) Maintains Migraine Drug Lead 9/30/2016
LabCorp (LH) Subsidiary Sequenom (SQNM) Announces Early Tender Results For Tender Offers And Successful Completion Of Consent Solicitations For 5% Convertible Senior Notes Due 2017 And 5% Convertible Senior Exchange Notes Due 2018 9/30/2016
Sunshine Heart Realigns Strategy to Focus on Aquadex FlexFlow System 9/30/2016
Delcath Systems (DCTH) Prices Underwritten Public Offering Of Common Stock And Warrants 9/30/2016
Why Cash Is King For Biotech Stocks 9/30/2016
Delcath Systems (DCTH) Announces Proposed Public Offering Of Common Stock And Warrants 9/30/2016
Unilife  (UNIS) Provides Trading Update 9/30/2016
Sinovac Biotech Ltd. (SVA) Schedules 2016 Annual Meeting Of Shareholders 9/30/2016
Acorda (ACOR) Gains Title To Biotie Shares And The Shares Will Delist 9/30/2016
Human Genome, DNA, The New Themes Of Samsung Biologics Focuses 9/30/2016
JW Group Vows To Foster C&C Research Labs As Global Biotech Firm 9/30/2016
CXR Biosciences To Expand Its Mechanistic Toxicology Services Following Scientific Advisory Board Endorsement 9/30/2016
4 Biotech Stars That Will Beat the Stock Slump 9/29/2016
3 Biotech Stocks to Steer Clear of 9/29/2016
Celgene (CELG) Could Dethrone Biogen (BIIB) in Multiple Sclerosis 9/29/2016
GM&C Life Sciences Fund Invests In SwabTech 9/29/2016
GlaxoSmithKline (GSK) Vaccines For Malaria, Zika Make It A Likely Winner 9/29/2016
Apricus Biosciences (APRI) Closes $3.7 Million Registered Direct Offering 9/29/2016
InspireMD Announces 1-for-25 Reverse Stock Split 9/29/2016
Endonovo At The Intersection Of Stem Cells And Biologics For Next Generation Therapeutics - SECFilings.com 9/29/2016
Actinium (ATNM.OB) Announces Pricing of Public Offering of Common Stock 9/29/2016
Otonomy (OTIC) To Host Investor And Analyst Day On October 7, 2016 9/29/2016
3 Biotechs With Key Decisions Pending in the Next 18 Months 9/28/2016
Eli Lilly (LLY)'s Alzheimer's Drug Could Potentially Bring in Billions 9/28/2016
Foamix Pharma (FOMX) Announces Proposed Follow-On Offering Of Ordinary Shares 9/28/2016
Array BioPharma (ARRY) Announces Proposed Public Offering Of Common Stock 9/28/2016
MyoKardia Announces Pricing Of Proposed Public Offering Of Common Stock Publication 9/28/2016
Foamix Pharma (FOMX) Announces Pricing Of Its $57 Million Follow-On Offering Of Ordinary Shares 9/28/2016
Top 25 Biotechs Of 2016 9/28/2016
MMJ PhytoTech Ltd Unlocking Near-Term Value And Optimising Assets For Growth 9/28/2016
A Look at What's Next for Pfizer (PFE), More Acquisitions Could Come 9/27/2016
Two Promising Biotech Stocks Under $5, and One to Avoid Like the Plague 9/27/2016
Novan Announces Closing Of Initial Public Offering 9/27/2016
MyoKardia Announces Proposed Public Offering Of Common Stock 9/27/2016
Intrexon (XON) Grants Employment Inducement Award Pursuant To NYSE Rule 303A.08 9/27/2016
Rasna Therapeutics (ATVM) Announces Forward Split Of Common Stock, Name Change & Ticker Change To RASP 9/27/2016
Nexus BioPharma Provides Business Outlook And Sets Corporate Milestones 9/27/2016
TxCell Announces First-Half 2016 Financial Results and Provides Strategy Update 9/27/2016
Aquinox (AQXP) Announces Closing Of $75.4 Million Public Offering Of Common Stock, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares 9/26/2016
KaloBios (KBIO) Now Current On SEC Periodic Filings 9/26/2016
Aquinox (AQXP) Announces Closing Of $75.4 Million Public Offering Of Common Stock, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares 9/26/2016
BioPharmX Announces Registered Direct Offering 9/26/2016
Ironwood (IRWD) Closes $150 Million Debt Refinancing 9/26/2016
Palatin Tech (PTN) Receives Audit Opinion With Going Concern Explanation 9/26/2016
Unilife  (UNIS) Announces Receipt Of Delinquency Letter From NASDAQ Relating To Fiscal 2016 Form 10-K 9/26/2016
Nolato AB ( NOLA-B.ST): Acquisition Conference Call Today At 3.30 PM CET 9/26/2016
Pfizer (PFE) Decides Remaining One Company Best Positions Company To Maximize Future Value Creation 9/26/2016
Arbitral Tribunal Confirmed Acorda (ACOR)'s Redemption Right Regarding Biotie Shares And Biotie Shares Trading Has Been Terminated 9/26/2016
Becton, Dickinson and Company (BDX) Investing $100 Million to Expand Nebraska Syringe Plant 9/23/2016
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 9/23/2016
Ascendis Pharma A/S Announces Webcast Of R&D Update 9/23/2016
Apricus Biosciences (APRI) Announces $4.6 Million Registered Direct Offering 9/23/2016
Venaxis (APPY) Reports Option Inducement Grants For New Employees Under NASDAQ Listing Rule 5635(C)(4) 9/23/2016
China Cord Blood To Hold Annual General Meeting In Hong Kong On December 9, 2016 9/23/2016
IntelliPharmaCeutics Responds To Recent Trading Activity 9/23/2016
Catabasis (CATB) Announces Pricing Of $10 Million Offering Of Common Stock 9/23/2016
2 of the Cheapest Stocks in Biotech 9/23/2016
This Secretive Tech Startup Worth $5 Billion Might Be Total Bull Crap 9/23/2016
Eleven Bio (EBIO) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/23/2016
Fogarty Institute Accepting Applications for Medical Technology Startups 9/23/2016
Sarepta (SRPT) Announces Pricing Of $300 Million Public Offering Of Common Stock 9/23/2016
CTI BioPharma Granted 180 Day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule 9/22/2016
Roka Bioscience, Inc. (ROKA) Completes Private Placement Of Preferred Stock And Warrants 9/22/2016
VistaGen Therapeutics, Inc. Provides Business Outlook And Sets Corporate Milestones 9/22/2016
Orexo (ORXOF): Issue And Repurchase Of Class C Shares 9/22/2016
Pfizer (PFE) Declares 30-Cent Fourth-Quarter 2016 Dividend 9/22/2016
Early-Cancer Detection Company iCareDx Announces Corporate Name Change To Acuamark Diagnostics 9/22/2016
Agilent (A) Announces Cash Dividend Of 11.5 Cents Per Share 9/22/2016
Eleven Bio (EBIO) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/22/2016
Sarepta (SRPT) Announces Proposed Public Offering Of Common Stock 9/22/2016
Alnylam (ALNY) Reports Inducement Grant To New Chief Operating Officer 9/22/2016
Huons Global Of Korea Puts China First In Globalization Effort 9/22/2016
Novan Announces Pricing Of Initial Public Offering Of Common Stock 9/21/2016
Blame Game: The $130 Billion In Fees Mylan (MYL) Says Pushes Up Prices 9/21/2016
Biotech Is Making A Comeback-Here's How To Play It 9/21/2016
How Medtronic (MDT), Now Based in Ireland, Still Reaps U.S. Benefits 9/21/2016
CareDx (CDNA) Announces Proposed Public Offering Of Common Stock 9/21/2016
Agios (AGIO) Announces Closing Of Public Offering And Full Exercise Of Option To Purchase Additional Shares 9/21/2016
Behind Battle Over Drug Prices, Quiet Money From Big Pharma 9/20/2016
Aquinox (AQXP) Prices Public Offering Of Common Stock 9/20/2016
Director Increases Ownership In GeneNews (GEN.TO) 9/20/2016
Shire (SHPG) Prices Public Offering Of Senior Notes 9/20/2016
Aquinox (AQXP) Announces Proposed Public Offering Of Common Stock 9/20/2016
Galapagos (GLPG.BR) Increases Share Capital Through Warrant Exercises 9/20/2016
GM&C Life Sciences Fund Makes Further Seed Investments 9/20/2016
Acelity Announces Early Tender Results For The Exchange Offer And Successful Completion Of The Consent Solicitation With Respect To Senior Notes Due 2019 9/20/2016
Pfizer (PFE) Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts 9/20/2016
Zomedica Graduates To Tier 1 Of The TSX Venture Exchange 9/19/2016
Hemispherx (HEB) Regains Compliance With NYSE MKT Continued Listing Standards 9/19/2016
EXACT Sciences (EXAS) Grants Inducement Restricted Stock Unit Awards To Recently Hired Employees 9/19/2016
Misonix (MSON) Reports Receipt Of Deficiency Letter From The Nasdaq Stock Market LLC 9/19/2016
Telesta (TSX:TST) Publishes Its Annual Financial Statements And Provides Date Of Special Shareholders Meeting 9/19/2016
Spotlight Innovation Announces Debt Restructuring Through Conversion Of $850,000 In Convertible Promissory Notes 9/19/2016
LabCorp (LH) Subsidiary Sequenom (SQNM) Announces Tender Offers And Consent Solicitations for 5% Convertible Senior Notes Due 2017 And 5% Convertible Senior Exchange Notes Due 2018 9/19/2016
Innovus Pharma Beyond Human Platform, Reaching Between 20-30 Million People On A Monthly Basis, Propels High Margin Sales -- SECFilings.com 9/19/2016
Osiris (OSIR) Provides Update Regarding NASDAQ Listing Status 9/19/2016
Company Profile For MOF Technologies 9/16/2016
Agilent (A) Announces Offering Of Senior Notes 9/16/2016
PharmAthene, Inc. (PIP) Announces Receipt Of Payments From SIGA (SIGA) 9/16/2016
Capricor Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock 9/16/2016
Vertex (VRTX) Looks To Cash In On Its Rich Drug Pipeline 9/16/2016
The Single Most Important Metric To Determine If Valeant (VRX) Is A Buy 9/16/2016
Misonix (MSON) Will Miss Deadline Filing, Appoints Interim CFO 9/16/2016
Capricorn Pharma Inc. Announces Pricing Of Offerings Of Common Stock 9/16/2016
Roka Bioscience, Inc. (ROKA) Prices Private Placement Of Preferred Stock And Warrants 9/16/2016
uniQure (QURE) Receives NASDAQ Deficiency Letter Related To Board Composition 9/16/2016
Science Center Pilots Program Aimed At Engaging High School Students With STEM 9/16/2016
Aerie (AERI) Announces Public Offering Of Common Stock 9/16/2016
Aerie (AERI) Raises $125 Million In Public Offerings 9/16/2016
Agilent (A) Prices $300 Million Of Senior Notes 9/16/2016
Let's Hear It for the Yale Professor Who Launched New Biotech Kleo 9/15/2016
Immune Design Corporation (IMDZ) Announces Proposed Public Offering Of Common Stock 9/15/2016
Immune Design Corporation (IMDZ) Prices Public Offering Of Common Stock 9/15/2016
Agios (AGIO) Announces Pricing Of $150 Million Public Offering Of Common Stock 9/15/2016
Alere (ALR) Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock 9/15/2016
Proteostasis (PTI) Announces Closing Of Follow-On Public Offering Of Common Stock 9/15/2016
TapImmune (TPIV) Announces Reverse Stock Split In Preparation For Proposed Uplisting To NASDAQ Capital Market 9/15/2016
Daxor Corporation (DXR) Announces Filing Of Form N-CSR for June 30, 2016 9/15/2016
CEN Biotech Notice To Shareholders 9/15/2016
Tiziana Life Sciences Plc: Confirmation of Capital Reduction 9/15/2016
Abbott (ABT) Declares 371st Consecutive Quarterly Dividend 9/15/2016
Portage Biotech's Chairman Issues Letter To Shareholders 9/15/2016
Resverlogix (RVX.TO) Announces Filing Of Quarterly Financial Statements And Management's Discussion & Analysis 9/15/2016
OvaScience (OVAS) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/15/2016
Thermo Fisher Scientific (TMO) Prices Offering Of Senior Notes 9/15/2016
Great Basin Scientific Announces Reverse Stock Split Of Common Stock 9/15/2016
Lachesis Biosciences ASX Initial Public Offer - Prospectus And Application 9/15/2016
Good or Bad? Pharma Bro Thinks Jazz Pharma (JAZZ) Could be Worth $20 Billion, Calls Mast Therapeutics (MSTX) 'Worthless' 9/14/2016
Everything's Bigger in Texas: Aeglea (AGLE) Quickly Growing into Leading Austin Biotech 9/14/2016
2 Bargain Pharma Stocks to Snag No Matter Who is Elected 9/14/2016
Novogen Limited (NVGN) Release: Conversion Of Convertible Notes 9/14/2016
Spherix (SPEX) Issues Letter To Shareholders 9/14/2016
Zynerba (ZYNE) Reports Inducement Grant To New Chief Financial Officer 9/14/2016
Catalyst Pharma (CPRX) Announces Launch Of Expanded Access Program Website And Participation At The American Association Of Neuromuscular & Electrodiagnostic Medicine Conference 9/14/2016
More Biotech Deal-Making: A Potential Silver Lining Of Pharma Price Pressure 9/14/2016
These 5 Biotech Stocks Are Ready for a Volatility Break 9/14/2016
PetLife Pharma Continues Execution Of Its Vitalzul TM Business Plan With Start Of Proof Of Concept Studies; Provides Updates 9/14/2016
Agios (AGIO) Announces Proposed Offering Of Common Stock 9/14/2016
Acelity Announces Pricing Of $1,750 Million Of 9.625% Second Lien Senior Secured Notes 9/14/2016
Bioz Launches Ambassador Program To Accelerate The Pace Of Scientific Research And Drug Discovery 9/14/2016
Medifirst Solutions Announces Shareholder Update 9/14/2016
AEterna Zentaris (AEZS) Announces Expiration Of Remaining Series B Warrants 9/14/2016
IMS Health Announces Pricing On Upsized Offering Of Senior Notes In Connection With Quintiles (Q) IMS Merger 9/14/2016
Will FDA’s Scrutiny of Pfizer (PFE)’s Chantix Trial Go Up in Smoke? 9/13/2016
5 Biotech Stocks That Brokers LOVE LOVE LOVE 9/13/2016
How Medivation (MDVN) and This Little Biotech Turned $8,000 Into $250,000+ for Investors 9/13/2016
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 9/13/2016
Perrigo (PRGO) Acknowledges Receipt Of Letter From Starboard Value LP 9/13/2016
Abzena Release: AGM Business Update 9/13/2016
Cerebain Biotech Presents Update On Its Medical Device Research And Development As It Continues Its Battle Against Alzheimer’s And Dementia 9/13/2016
Innovus Pharma's (INNV) RecalMax An Effective Supplement In The $11 Billion Neurodegenerative Market -- SECFilings.com 9/13/2016
Atossa Genetics (ATOS) Regains Compliance With NASDAQ Listing Requirement 9/13/2016
Great Basin Corporation Announces Annual Meeting Results 9/13/2016
Nordic Nanovector – Notification Of Share Capital Increase 9/13/2016
Acelity Announces Pricing Of $1,750 Million Of 9.625% Second Lien Senior Secured Notes 9/13/2016
The Five Deadly Sins Of Big Pharma 9/12/2016
Adamas Pharma (ADMS) Announces New Employment Inducement Grant 9/12/2016
CytoDyn (CYDY) Announces $10.0 Million Registered Direct Offering 9/12/2016
IMS Health Announces Offering Of Senior Notes In Connection With Quintiles (Q) IMS Merger 9/12/2016
Activist Investor Calls on Perrigo (PRGO) to Explore Sale of Prescription Pharma Biz, Refocus on Core Business 9/12/2016
BioAmber Closes On A $19.2 Million Corporate Loan 9/12/2016
Development-Stage Biotech Renova Therapeutics Partners With NASDAQ Private Market 9/12/2016
Advantagene Closes $14.2 Million In Private Placement Financing To Advance Immuno-Oncology Clinical Programs 9/12/2016
SAGE Therapeutics (SAGE) Announces Pricing Of Public Offering Of Common Stock 9/9/2016
Lantheus Medical Imaging Announces Public Offering Of 5,200,000 Shares Of Common Stock 9/9/2016
Juno (JUNO), Nektar Therapeutics (NKTR) CEOs Sold $1 Million of Stock Before Labor Day 9/9/2016
Investors: Here's What You Need to Know About Gilead (GILD) and Roche (RHHBY) 9/9/2016
Alcami Announces Completion Of Site Investment And Expansion In Drug Product Manufacturing And Development Facilities 9/9/2016
CoLucid Pharma (CLCD) Announces Pricing Of Public Offering Of Common Stock 9/9/2016
Proteostasis (PTI) Announces Pricing Of Public Offering Of Common Stock 9/9/2016
Thermo Fisher Scientific (TMO) Prices Offering Of Euro-Denominated Senior Notes 9/8/2016
Sunesis (SNSS) Announces 1-for-6 Reverse Stock Split 9/8/2016
MabVax Therapeutics Issues Letter To Shareholders Post Uplisting Onto The Nasdaq Capital Market 9/8/2016
SAGE Therapeutics (SAGE) Announces Proposed Public Offering Of Common Stock 9/8/2016
Pulse Biosciences Provides Overview Of Corporate Strategy And Updates On Clinical Development For Novel Pulsetx Platform 9/8/2016
Insulet (PODD) Announces Pricing Of Convertible Senior Notes Due 2021 9/8/2016
Venture Capital: Evonik Industries Invests In Irish Medical Device Company Vivasure Medical 9/8/2016
Taking a Look at 3 Stocks That are Better Buys Than Gilead (GILD) 9/8/2016
5 Biotechs Under $10 With Massive Potential 9/8/2016
Investors Wait Patiently for Gilead (GILD) and Its CEO to Make a M&A for Growth and to Get Out of Share Slump 9/7/2016
Organovo (ONVO) Announces Initiation Of Commercial Contracting For Exvive Human Kidney Tissue 9/7/2016
Immune Pharma Receives $2 Million Investment In Common Stock At $0.50 Per Share 9/7/2016
Aviragen Announces Inducement Grant For New Employees 9/7/2016
Peregrine (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 9/7/2016
Cerus (CERS) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/7/2016
Catalent (CTLT) Announces Secondary Public Offering Of Common Stock 9/7/2016
Insulet (PODD) Announces Private Offering Of Convertible Senior Notes 9/7/2016
Great Basin Scientific Receives Delisting Warning from Nasdaq 9/7/2016
TapImmune (TPIV) Issues Update: Multiple Phase 2 Trials, Over $9 Million In New Funding & NASDAQ Uplisting Application 9/6/2016
Shire (SHPG): U.S. Securities And Exchange Commission Filings 9/6/2016
NASDAQ Accepts NW Bio (NWBO) Remediation Plan For Shares And Warrants Previously Issued To Cognate BioServices, Inc. 9/6/2016
Faron Pharmaceuticals Ltd. Release: Interim Results 2016: Progress Continued In Traumakine Phase III And With Clevegen Indications Extended 9/6/2016
University City Science Center Receives SBA Funding For Newest Commercialization Program 9/6/2016
Acelity Announces Exchange Offer And Consent Solicitation With Respect To Senior Notes Due 2019 9/6/2016
Juno (JUNO), Kite Pharma (KITE) Fall After Novartis AG (NVS) Dissolves CAR-T Unit 9/6/2016
PAREXEL (PRXL) Loses $160 Million in Value in One Day After Disclosing Possible 'Misappropriation of Corporate Funds' 9/2/2016
Why Boston Scientific (BSX)'s Stock Could Rise Another 40% 9/2/2016
KaloBios (KBIO) Files Outstanding 10-Q And 10-K for 2015 9/2/2016
RespireRx (RSRX) Announces 1-for-325 Reverse Stock Split 9/2/2016



//-->